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Abstract
Background: Despite its role in increasing the number of offspring during the lifetime of an individual animal,
controlled ovarian hyperstimulation (COH) may have detrimental effects on oocyte development, embryo quality
and endometrial receptivity. Circulating miRNAs in bio-fluids have been shown to be associated with various
pathological conditions including cancers. Here we aimed to investigate the effect of COH on the level of
extracellular miRNAs in bovine follicular fluid and blood plasma and elucidate their mode of circulation and
potential molecular mechanisms to be affected in the reproductive tract.
Method: Twelve simmental heifers were estrous synchronized and six of them were hyperstimulated using FSH.
Follicular fluid samples from experimental animals were collected using ovum pick up technique at day 0 of the estrous
cycle and blood samples were collected at day 0, 3 and 7 of post ovulation. The expression profile of circulatory miRNAs
in follicular fluid and blood plasma were performed using the human miRCURY LNA™ Universal RT miRNA PCR array
system. A comparative threshold cycle method was used to determine the relative abundance of the miRNAs.
Results: A total of 504 and 402 miRNAs were detected in both bovine follicular fluid and blood plasma, respectively. Of
these 57 and 21 miRNAs were found to be differentially expressed in follicular fluid and blood plasma, respectively
derived from hyperstimulated versus unstimulated heifers. Bioinformatics analysis of those circulating miRNAs indicated
that their potential target genes are involved in several pathways including TGF-beta signaling pathway, MAPK signaling
pathway, pathways in cancer and Oocyte meiosis.
Moreover, detail analysis of the mode of circulation of some candidates showed that most of the miRNA were found to
be detected in both exosomal and Ago2 protein complex fraction of both follicular fluid and blood plasma.
Conclusion: Our data provide the consequence of hyperstimulation induced changes of extracellular miRNAs in bovine
follicular fluid and blood plasma, which may have a potential role in regulating genes associated not only with bovine
ovarian function but also involved in altering various physiological in bovine oocytes, embryos and modulating
reproductive tract environment.
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Background
Follicular development is a dynamic process which in-
volves emergence of a group of follicles after an increase
of peripheral concentration of follicle stimulating hor-
mone (FSH) [1]. Follicular products from the dominant
follicle are responsible for suppressing FSH concentration
and leading to atresia of the subordinate follicles [2, 3].
Meanwhile, dominant follicle acquires LH receptors in its
granulosa cell and no longer dependent of FSH for further
development. Maintenance of elevated level of circulating
FSH rescues the subordinate follicles from regression, re-
sulted in the growth of multiple dominant follicles with
ovulating capability [4]. Therefore, Controlled ovarian hy-
perstimulation (COH) is utilized to stimulate the growth
of multiple follicles in naturally mono-ovulating species,
including cattle and humans, by maintaining supraphysio-
logical level of gonadotrophin.
Although COH is the central component of ART, it is
recently became evident that COH may have detrimental
effects on oocyte development, embryo quality, endo-
metrial receptivity and perhaps on perinatal outcomes
[5]. In vitro studies showed that ovarian stimulation dis-
rupts and delays early embryonic development in mouse
[6, 7]. We have previously shown that changes in the bo-
vine oviduct and uterine environment induced by go-
nadotrophin treatments has resulted in changes in gene
expression profile of the resulting blastocysts [8]. Fur-
thermore, an increase in chromosomal abnormalities has
also been reported in human embryos after conventional
stimulation, mainly resulting from an increased inci-
dence of chromosome segregation errors during the first
embryonic divisions [9]. It is well known that COH leads
to deviant oocyte development in the follicle [10] as a re-
sult of nonphysiological endocrine level in the reproductive
organs. Follicular development is a complex coordinated
process facilitated by the bidirectional signalling between
gonadal and somatic cells in follicular microenvironment.
A large number of gene products are involved in this
process, which are expressed in cell type and time
dependent manner Any deviation in the expression of
these genes due to environmental factors could lead to ab-
normal oocyte development, apoptosis, and poor cellular
communication with the companion somatic cells [11]. In
this context the role of miRNAs as post transcriptional reg-
ulaters of gene expression can not be ruled out as these
regulatory molecules are abundantly expressed in follicular
cells and in extracellular space in follicular microenvir-
onment. MicroRNAs (miRNAs) are a class of small
non-coding RNAs that regulate gene expression at the
post-transcriptional level. miRNAs have been found in
all mammalian tissues and cell types examined so far
and play important roles in a variety of physiological
and pathological processes [12]. While majority of miR-
NAs are detected intracellular, a handful number of
miRNAs are also detected in extracellular body fluids
such as plasma, serum, urine, saliva and follicular fluid
[13–15]. Although the origin of cell-free miRNAs in cir-
culation is not entirely clear, miRNAs are believed to be
released to the extracellular space from damaged or
apoptotic cells and are also actively secreted by cells via
exosomes or exocytosis [13]. Circulating miRNAs have
been shown to be useful biomarkers for multiple clinical
endpoints including the diagnosis of preeclampsia [16],
the diagnosis and monitoring of diabetic retinopathy
[17], neuropathy [18] and as diagnostic or prognostic
markers for multiple cancers [14, 19–22]. Cellular release
of miRNA molecules into the circulation has been shown
to be associated with the altered physio-pathological con-
ditions. The function of exosomes and shedding vesicles
are believed to be cell-to-cell communication and plat-
forms for multi signalling processes [23, 24].
Circulating miRNAs have been extensively studied
since their discovery [13, 14], and they are known to be
coupled with vesicles, in particular microvesicles or exo-
somes [25] or high density lipoproteins (HDL) [24, 26, 27]
and protein complexes [28–30] and their presence in the
blood has been attributed to release by tissue injury. We
have recently demonstrated that the presence of extracel-
lular miRNAs in bovine follicular fluid and their associ-
ation with the growth status of oocytes [15]. However,
effect of gonadotrophin treatments during COH on extra-
cellular miRNAs in follicular fluid and blood plasma has
not been investigated yet in mammalian species. There-
fore, the aim of this study was to test the hypotheses that
controlled ovarian hyperstimulation may change the
extracellular miRNA population in follicular fluid and
blood plasma of cyclic heifers, which may be involved in
various physiological processes. For this a qRT-PCR array
based expression profiling was used to identify a panel of
differentially expressed circulating miRNAs in follicular
fluid samples and blood plasma samples of hyperstimu-
lated compared to unstimulated heifers. Moreover, the
bioinformatics analysis of the candidate miRNAs revealed
the potential involvement of those miRNAs in regulation
of several signaling pathways, which are known to be ac-
tive in various key reproductive processes.
Methods
Animal treatments and sample collection
All experimental animals were handled according to the
animal protection law of Germany. The experiment was ap-
proved by the Animal Welfare committee of the University
of Bonn with proposition number 84–02.05.20.12.075. Sim-
mental heifers (n =10), aged from 15 to 17 months and
weighing between 380 to 450 kg were used in this study.
All animals were kept under identical farm conditions
within the same herd. Synchronization and ovarian hyper-
stimulation was performed according to the previously
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mentioned protocol [8] Briefly, pre-synchronization was
performed for all animals by intra-muscular administra-
tion of 500 mg of cloprostenol (PGF2a, Estrumatew; Essex
Tierarznei, Munich, Germany) twice within 11 days. Two
days after each of the PGF2a treatments animals received
10 mg of GnRH (Receptalw; Intervet, Boxmeer, the
Netherlands). Of 10 synchronized heifers 6 were used for
hyperstimulation in which twelve days after the last GnRH
injection, these heifers received the first of eight consecu-
tive FSH-injections over 4 days in decreasing doses (in
total 300–400 mg of FSH equivalent according to the body
weight; Stimufol, University of Liege, Belgium). Two
PGF2a treatments were performed 60 and 72 h after the
initial FSH injection. Finally, 48 h after the application of
first PGF2a, ovulation was induced by simultaneous ad-
ministration of 10 mg of GnRH. Afer 60 h of first PGF2a
application was considered as onset of oestrus (D0). Fol-
licular contents (follicle 35 mm) were collected by transva-
ginal, ultrasound-guided follicular aspirations. Follicular
fluid was collected using a 12-gauge needle, centrifuged at
1500 × g for 5 min, and later stored at −80 °C, while blood
samples were collected from each animal from day 0 (D0),
day 3 (D3) and day7 (D7) by tail vein puncture. Blood
serum following collection, blood samples were refriger-
ated at 4 °C for 12–24 h before being centrifuged at
1500 × g at 4 °C for 15 min. Serum was separated and
stored at −20 °C until assayed to determine progesterone
concentration. Blood plasma for miRNA detection was col-
lected by EDTA Tubes (Carl Roth, Karlsruhe, Germany)
from the both group animals and stored at −80 °C until
processed for microvesicles/ exosomes, RNA, or protein
isolation.
Progesterone assay
Serum progesterone concentration in different time
points was determined by time-resolved immunofluores-
cence using an Auto DELFIA™ Progesterone kit (Perkin
Elmer, Wallac Oy, Turku, Finland) which is based on the
fluorescence of elements where the assay sensitivity was
0.01 ng/ml. The assay principle combines an enzyme im-
munoassay competition method with final fluorescent
detection. The DELFI test is based on the competition
for binding sites on the antibody molecule that occurs
between the Europium + 3-labeled hormone and a not-
labeled hormone, contained in the sample. The amount
of the labeled hormone is constant, whilst the not-
labeled hormone content is a function of antibody- la-
beled hormone complex formation. On this basis, a
standard curve was drawn for reading the hormone
levels in the sample.
Isolation total RNA and reverse transcription
Total RNA was isolated from follicular fluid and blood
plasma, ultracentrifugation pellets and immunoprecipitation
pellets using the miRNeasy kit (Qiagen, Hilden, Germany)
according to the manufacturer’s protocol with some modi-
fications. Briefly, 800 μL of QIAzol buffer was added to
200 μL of plasma or follicular fluid or exosome pellet or
Ago2 pellet and incubated at room temperature for 8 min.
After that to inactivate RNases activity 200 μL chloroform
was added to each sample. At that point, the manufac-
turer’s protocol was followed. Total RNA concentration
and purity was determined using NanoDrop ND-1000
spectrophotometer. Moreover, prior to reverse transcrip-
tion procedure RNA samples from both plasma and fol-
licular fluid were checked for the presence or absence of
PCR inhibitors described elsewhere [15]. Briefly, cDNA
was synthesized using different input volume, for instant
0.5 μl, 1 μl, 2 μl and 4 μl of total RNA, in 10 μl of reaction
volume and quantify the expression of selected miRNA
using qPCR. All RNA samples showed linear amplification
of the candidate miRNAs for different levels of RNA in-
put, which showed the absence of PCR inhibitors and
good quality RNA (data not shown). A reverse transcrip-
tion reaction was performed using the miRCURY LNA™
Universal RT microRNA PCR system (Exiqon, Denmark)
according to the manufacturer’s instructions. In brief, ap-
proximately a total of 100 ng of total RNA, including
small RNA, were anchor-tailed with a poly(A) sequence at
their 3'end and then reverse transcribed into cDNA using
a universal poly(T) primer with a 3'end degenerate anchor
and a 5' end universal tagged.
miRNA Profiling and expression analysis
The expression of miRNAs in blood plasma and follicu-
lar fluid were profiled using miRNA Ready-to-Use PCR,
Human Panel I &II, V2.M qRT-PCR arrays (Exiqon,
Vedbaek, Denmark) which contains 748 mature miRNA
sequences along with 8 empty wells, 6 intra-plate cali-
brators and 6 endogenous controls. A SYBR green based
real time PCR technology was employed for signal de-
tection during quantification. Prior to real time PCR
analysis the cDNA products from each samples were di-
luted 100-fold and mixed with ready to use SYBR-green
master mix. Then the cDNA-master mix was robotically
pipette to a 384-well PCR plate containing miRNA spe-
cific primers. The real time PCR was run on a ABI-
7900HT thermocycler (Applied Biosystems) using the
following thermal-cycling parameters: 95 °C for 10 min,
40 cycle of 95 °C for 10 sec, 60 °C for 1 min followed by
a melting curve analysis. Raw Ct values were calculated
as recommended by Exiqon using the RQ manager soft-
ware v1.2.1 (Applied Biosystems), and Ct values were cal-
culated by using automated assay-specific baseline and
threshold settings. To minimize the potential noise, miR-
NAs with Ct value greater than 35 in all groups were con-
sidered as undetected. The PCR data were analysed using
web-based PCR array data analysis software (http://
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pcrdataanalysis.sabiosciences.com/pcr/arrayanalysis.php-).
The raw miRNA data was normalized using a global
normalization method.
Target prediction and pathway analysis
Target Scan 6.2 and miRDB were used to predict the tar-
get genes of the differentially expressed miRNAs in both
follicular fluid and blood plasma of hyperstimulated and
unstimulated groups. The predicted miRNA target genes
were analyzed by using the DAVID Bioinformatic Re-
source (http://david.abcc.ncifcrf.gov/) server for Annota-
tion, Visualization, and Integrated Discovery to identify
the pathway distribution. These pathways were pre-
sented according to the Kyoto Encyclopedia of Genes
and Genomes (KEGG) database (http://www.genome.jp/
kegg/). Fisher’s exact test was used to calculate a p-value
determining the probability that each biological function
or canonical pathway assigned to the data set. In
addition, the significance of the association between the
data set and the canonical pathway was calculated as the
ratio of the number of genes from the data set that were
mapped to the pathway divided by the total number of
genes that mapped to the canonical pathway.
Exosome isolation
Exosomes were isolated from 400 μL follicular fluid and
blood plasma using differential ultra-centrifugation as
previously described [15] with some modification.
Briefly, samples were subjected to centrifugation at
4,000 × g for 10 min to remove cell and cell debris. Cell
free plasma samples were then filtered through 0.22 μm
screen to remove particles larger than 200 nm. Purified
plasma were diluted into 4 mL of DPBS (life technolo-
gies, paisley, UK) solution and mixed gently. Samples
were ultracentrifuged in 5-mL (13 × 51 mm) polyallomer
tubes (no. 326819; Beckman Coulter) at 120,000 × g for
70 min at 4 °C in a swinging-bucket SWTi 55 rotor. The
resulting supernatant was removed and exosomes pellets
were resuspended in DPBS solution and centrifuged
again at 120,000 × g for 70 min at 4 °C. Finally, the
resulting pellet was resuspended in 200 μL DBPS and
stored for further use.
Immunoprecipitation Ago2 protein complex
A total of 400 μL of plasma was used from each group
to immunoprecipitate Ago2 protein in order to isolate
Ago2 coupled miRNAs. Each plasma sample was diluted
with 400 μL of DPBS (pH 7.4) resulting 800 μL of diluted
plasma. Following this, 400 μL of Magna Bind goat anti-
mouse IgG Magnetic Bead slurry (Thermo Scientific,
Rockford, USA) were washed in DPBS and incubated with
10 μg of mouse monoclonal anti-Ago2 mouse normal IgG
(Santa Cruz Biotechnology Inc, USA) antibodies for 2 h at
4 °C. The pre-incubated beads and antibody were then
added to the 800 μL of diluted plasma and incubated over-
night at 4 °C. Beads were washed three times with 1 %
Nonidet P-40 buffer (1 % Nonidet P-40, 50 mM Tris–
HCl, pH 7.4, 150 mM NaCl, 2 mM EDTA (BD Bioscience,
Heidelberg, Germany). After the final wash 800 μL of
QIAzol lyses buffer was added directly to the Ago 2 pellet
and processed for RNA isolation.
Western blot analysis
Exosomal and Ago2 immunoprecipitate proteins were iso-
lated from organic phenol part during total RNA isolation
using miRNeasy mini kit (Qiagen, Hilden, Germany) and
resuspended in 8 M Urea. Approximately 20 μg of protein
from each sample were resolved in 12 % SDS-PAGE poly-
acrylamide gel (Bio-Rad, Corp., Hercules, CA, USA) and
immune reactive proteins were visualized with a Chemidoc
XRS (Bio-Rad) instrument. CD63 (ExoAB Antibody, SBI,
CA, USA) was used to check the efficiency of exosomes
isolation, while Ago2 antibody (Santa Cruz Biotechnology
Inc, USA) was employed to detect the efficiency of Ago2
immunoprecipitation.
Individual qRT-PCR Assays
Based on their enrichment in follicular fluid and blood
plasma from hyperstimulated heifers, 11 candidate miR-
NAs were selected for further study. Moreover, high
merit was given to those miRNAs which has sequence
similarities between human and bovine during the selec-
tion of candidate miRNAs. Primer sets of individual
qRT-PCR assays for miRNAs: miR-212, miR-182, let-7 g,
miR-100, miR-877, miR-200c, miR-221, miR-103, miR-134,
miR-147 and miR-127-3p were obtained from Exiqon
(Vedbaek, Denmark). Reverse transcription reaction prod-
ucts were combined with SYBR Green master mix (Exiqon,
Vedbaek, Denmark) and loaded into the 96-well plates pre-
loaded with individual miRNA primers. Quantitative PCR
was run in a Step one plus real time PCR instrument (Ap-
plied Biosystems). Relative expression of each miRNA was
analysed using a comparative Ct (2-ΔΔCT) method and glo-
bal normalization strategy was employed to normalize the
data.
Statistical analysis
All experiments were performed a minimum of three
times. When two groups were compared (i.e., synchro-
nised vs. super ovulated) a Student’s t-test was used to
detect differences between treatment groups. A P value
of ≤ 0.05 was considered to be significant. Data are
expressed as mean ± SD of replicates.
Results
Progesterone profile of experimental heifers
Blood serum progesterone (P4) concentration at day 7 of
the experimental heifers was used to identify animals
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with improper stimulation phenotype. Of the 6 hypersti-
mulated heifers, while 4 have shown a significantly ele-
vated P4 level (>24 ng/mL) and considered as properly
stimulated, 2 heifers (P4 concentration < 23 ng/mL) con-
sidered as improperly stimulated and excluded from the
experiment. The progesterone concentration in blood
serum of the selected hyperstimulated and unstimulated
heifers at days 0 & 7 is presented in Fig. 1. The mean
progesterone concentration at day 7 was 25.17 ± 1.01
and 2.21 ± 1.19 ng/ml (p < 0.001) in the hyperstimulated
and unstimulated heifers, respectively.
Detection of miRNAs in bovine follicular fluid and blood
plasma
Here, we examined the abundance of mature miRNAs in
follicular fluid and blood plasma of hyperstimulated and
unstimulated groups using ready-to-use Human miRNA
Panels (I + II) (Exiqon, Denmark) covering 748 mature
human miRNAs. After comparative analysis between
mature human miRNA sequences used in PCR panels
and bovine mature miRNA sequence available in miR-
Base version 19 (http://www.mirbase.org/), around 241
miRNAs were found to be completely identical, while
126 miRNAs showed differences in size due to addition
or deletion of 1–5 nucleotides and 58 miRNA sequences
contained mismatches. However, no bovine homologous
sequences were matched for 323 miRNAs in the present
miRBase databank. A miRNA was considered to be de-
tected when its Ct value is less than 35 and present in at
least in 75 % of the samples. Of the 748 miRNA investi-
gated, while 504 miRNAs were detected in follicular
fluid, 402 miRNAs were detected in blood plasma
(Fig. 2). Among the detected miRNAs 373 miRNAs
were commonly detected in both follicular fluid and
blood plasma. However, 131 and 29 miRNAs were
detected exclusively in follicular fluid and blood plasma,
respectively.
Differential expression of extracellular miRNAs in
follicular fluid from hyperstimulated and unstimulated
heifers
After excluding 244 miRNAs (31.8 %) with a Ct value
above 35 from the dataset, 504 informative miRNAs
were analysed in follicular fluid samples. In order to
compare miRNA expression differences between follicu-
lar fluid from hyperstimulated (n = 4) and unstimulated
(n = 4) animals, first the raw data was normalized using
global normalization method (correction with the sum
of the expression levels of detected miRNAs), as it was
successfully used in previous study compared to spiked-
in miRNA or mammalian U6 [31]. Expression analysis of
the detected miRNAs in follicular fluid revealed that 57
miRNAs are differentially expressed between two groups
(with a fold change of ≥2 & p ≤ 0.05). Of these, 30 miR-
NAs (52.6 %) were found to be up-regulated, while 27
miRNAs (47.4 %) were down-regulated in hyperstimu-
lated animals compared to the unstimulated ones.
Among the up-regulated miRNAs, miR-212 and miR-
148b-5p showed the highest fold change regulation. On
the other hand, miR-100 and miR-877 showed the great-
est fold change regulation among the downregulated
miRNAs (Table 1).
Expression profile of circulatory miRNAs in blood plasma
derived from hyperstimulated vs. unstimulated heifers
The same PCR array platform was used to compare the
pattern of circulatory miRNA expression in blood
Fig. 1 Progesterone profile of experimental heifers: Serum progesterone
concentrations (ng/mL) for unstimulated controls and hyperstimulated
heifers. Data is presented as mean ± SD and *** designated a
significance level of p < 0.001
Fig. 2 Venn diagram showing the number of detected miRNAs in
follicular fluid and blood plasma. Out of 748 miRNAs investigated in
the PCR panel I + II, a total of 504 and 402 miRNAs were detected
(with threshold cycle value of ≤35 in real time PCR analysis) in
follicular fluid and blood plasma, respectively
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Table 1 Differential expression of extra miRNAs in follicular fluid and blood plasma obtained from hyperstimulated and
unstimulated heifers
Follicular fluid (Hyp vs. Unst) Blood plasma (Hyp vs. Unst)
MicroRNA Name Fold change P value MicroRNA Name Fold change P value
miR-643 51.36 0.032678 miR-708-3p 8.15 0.038772
miR-212 40.19 0.007121 miR-26b-3p 4.92 0.031749
miR-148b* 33.13 0.009156 miR-598 3.69 0.002565
miR-548j 23.84 0.031322 miR-423-3p 2.77 0.045389
miR-132 22.45 0.033763 miR-130b-5p 2.73 0.022855
miR-224* 13.98 0.008991 miR-576-5p 2.69 0.024159
miR-129-3p 11.4 0.005949 miR-221 2.66 0.016328
miR-33b 10.57 0.000110 miR-1468 2.63 0.016305
miR-202* 6.53 0.000805 miR-18a-3p 2.55 0.031849
miR-155* 6.51 0.039305 miR-181c 2.40 0.033951
miR-374a 5.2 0.040696 let-7 g 2.00 0.008124
miR-1207-5p 5.11 0.000203 miR-103 2.29 0.002404
miR-182 4.81 0.047938 miR-34a 2.13 0.023235
miR-103 4.49 0.006078 miR-125b −3.07 0.013367
let-7 g 4.23 0.012259 miR-410 −3.2 0.038659
miR-106b 3.96 0.034579 miR-127-3p −3.22 0.000817
miR-191 3.95 0.021379 miR-494 −3.23 0.008614
miR-542-5p 3.78 0.005687 miR-147 −3.63 0.047214
miR-505* 3.57 0.006276 miR-99a* −5.54 0.044064
miR-550a 3.19 0.046925 miR-134 −7.03 0.043678
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plasma at day 7 of oestrous cycle between two experi-
mental groups. By employing the same criteria for data
filtration, a total of 402 (54.8 %) informative miRNAs
were identified in blood plasma samples of both groups.
Among the detected miRNAs, 21 miRNAs were identi-
fied as differentially expressed (p < 0.05), of which 13
were overexpressed and 8 were underexpressed in the
plasma of hyperstimulated heifers (Table 1). The miRNA
expression in the hyperstimulated plasma compared to
the unstimulated control was increased by 2 to11-fold
but decreased by 2.8to 7-fold (Table 1). Among the over-
expressed miRNAs miR-20b-3p and miR-708-3p showed
the highest fold change regulation, while miR-153 and
miR-134 exhibit highest fold change among the down-
regulated miRNAs.
Cluster of miRNAs affected by ovarian hyperstimulation
in follicular fluid and blood plasma
MiRNA cluster represent group of miRNA genes located
within 10 Kb of distance on the same chromosome. To
test the hypothesis that controlled ovarian hyperstimula-
tion may affect the expression of individual or cluster
miRNAs, the genomic location of the 57 and 21 miR-
NAs that were differentially expressed in follicular fluid
and blood plasma of hyperstimulated heifers, respect-
ively, were determined. Subsequently, we found that ap-
proximately 18 % of the follicular fluid derived
differentially expressed miRNAs to belong to miRNA
clusters and the rest 82 % were individual miRNAs
(Fig. 3). Of those in blood plasma differentially expressed
miRNAs, 15 % were found to be present in clusters.
Variable numbersof miRNAs were present in each
cluster with minimum of two. For example, the miRNA
cluster miR-410 ~ 134, which is found to be differentially
expressed between hyperstimulated and unstimulated
heifers blood plasma, contained 3 miRNAs. Since miR-
NAs within the cluster may share a common gene pro-
moter and may be regulated as a single transcriptional
unit, it could be of interest to determine whether any
entire cluster changed in the same direction following
treatment. Subsequently, we found that all miRNAs
within all 6 clusters (Fig. 3) showed the same direction
of expression tended to change in the same direction as
the other members in that cluster.
miRNA target prediction and pathway analysis
As the number of experimentally validated targets of
miRNA is limited, we used the widely used TargetScan
and miRDB algorithm to obtain the list of genes pre-
dicted to be targeted by the differentially expressed miR-
NAs obtained from follicular fluid and blood plasma of
the experimental animals. Accordingly, 8311 and 8050
genes were predicted to be targeted by up- and down-
regulated miRNAs, respectively, between follicular fluid
from hyperstimulated vs. unstimulated heifers. To over-
come the limitation of DAVID Bioinformatic Resource
(limited processing ability: 3,000 genes), only top 100
genes were considered for each miRNA for further bio-
informatics analysis. Accordingly, after screening of the
long list of genes, 3000 and 2700 genes were identified
as potential targets of up- and down-regulated miRNAs,
respectively, in follicular fluid samples. Similarly, a total
of 6267 and 4982 genes were found to be potentially tar-
geted by up- and down-regulated miRNAs in blood
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plasma samples of the experimental animals. Following
screening, a total of 1300 and 800 genes were identified
as potential targets of up- and down-regulated miRNAs,
respectively, in blood plasma samples of hyperstimulated
versus unstimulated heifers. Finally the screened list of
genes from both follicular fluid and blood plasma sam-
ples were subjected to a pathway analysis using NCBI
DAVID Bioinformatic Resource 6.7 to identify the sig-
nificantly enriched canonical pathway (P < 0.05).
As shown in Table 2 and Table 3, among the several
list of pathways, MAPK signalling pathway and Wnt
signaling pathway are the most enriched pathways po-
tentially regulated by the differentially expressed miR-
NAs. In addition, pathways involved in various signal
transductions and cell-to-cell interaction including
ErbB signaling pathway, Axon guidance, Neurotrophin
signaling pathway, Endocytosis, Oocyte meiosis, TGF-
beta signaling pathway and Focal adhesion were among
the most enriched pathways for genes potentially tar-
geted by miRNAs derived from both follicular fluid and
blood plasma of hyperstimulated heifers. Taken to-
gether, these bioinformatics exploratory analyses sug-
gest that variation in the level of circulatory miRNAs in
follicular fluid and blood plasma might affect critical
pathways involved in follicular development and oocyte
maturation. As miRNAs target prediction algorithms
are known to contain both false positives and false neg-
atives, and our in silico pathway enrichment analysis is
Fig. 3 The number of miRNAs in each cluster and their distribution in bovine chromosomes. While clusters differentially expressed in follicular
fluid (a-e) comprise two miRNAs, clusters in blood plasma shown to comprise three miRNAs. Multiple miRNA clusters are affected in the follicular
fluid and blood plasma due to ovarian hyperstimulation. The number of miRNA genes in each cluster ranged from 2-3. In all clusters, the expres-
sion of miRNA genes in a particular cluster was in the same direction (the arrow ↑ for increased expression, and the arrow ↓ for decreased expres-
sion). Please note that differentially expressed miRNAs (≥2 fold and p < 0.05) in follicular fluid and blood plasma of hyperstimulated heifers
compared to the un stimulated ones are listed in Table 1
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based on mRNA genes predicted to be targeted by
extracellular miRNAs, a full understanding of the po-
tential functional role of extracellular miRNAs can only
be established using functional experiments.
Temporal expression of candidate circulatory miRNAs in
blood plasma across oestrus cycle
In order to explore the temporal changes in the expression
of circulatory miRNA especially in blood plasma of hyper-
stimulated heifers, the expression of candidate miRNAs
was investigated at different days during the estrous cycle
(Days 0, 3 and 7). As shown in Fig. 4 expression analysis
of candidate miRNAs (miR-221, miR-103, let-7 g, miR-
134, miR-147 and miR-127-3p) using qRT-PCR revealed
the presence of temporal changes in the pattern of expres-
sion depending on the time during the estrous cycle as
shown in Fig. 4. While four of the candidates namely.
miR-221, miR-103, miR-134 and miR-127-3p showed a
significant increase in abundance at day 7 of the estrous
cycle compared to days 0 and 3, miR-147 showed a de-
creasing pattern from day 0 to day 7. No significant
difference in the expression of let-7 g miRNA has been
observed between the days during estrous cycle.
Validation of exosomes and Ago2 protein complexes
isolated from follicular fluid and blood plasma
To determine the mode of circulation of candidate miR-
NAs in follicular fluid and blood plasma, the exosomal and
Ago2 protein fractions of the biological fluid samples were
isolated using differentially ultracentrifugation and immu-
noprecipitation procedures respectively. The specificity of
both isolation procedures was validated using a western
blot analysis of exosomes and Ago2 specific marker pro-
teins. Immunoblotting of CD63 protein showed the pres-
ence of strong band in the exosome fraction of both
follicular fluid and blood plasma samples, while the Ago2
protein band was evident in immunoprecipitated portion of
the samples (Fig. 5). Despite ignorable detection of Ago2
protein in exosome fractions, strong bands for CD63 and
Ago2 proteins in exosomes and Ago2 fraction, respectively
suggest the efficient recovery of exosomes and Ago2 pro-
tein complexes from follicular fluid and blood plasma.
Table 2 List of enriched pathways (p <0.05), in which genes predicted to be targeted by differentially expressed miRNAs (P <0.05)
between follicular fluid from hyperstimulated vs. unstimulated heifers
Pathway miRNAs involved P value Top genes
Overexpressed miRNAs (hyp vs. unst)
TGF-beta signaling pathway miR-106b, −132, −148b-5p, −182, −212, −374a, −548j 1.75E-07 TGFBR2, TGFB2, SMAD2, SMAD3, SMAD4, BMPR2
Axon guidance miR-22-5p, −30b, −31, −33a-3p, −182, −132, −550a 2.85E-06 EFNB1, DCC, EPHB4, EPHA3, PLXNA1, PAK4
MAPK signaling pathway miR-30b, −106b, −132, −182, −212, −548j, −202-5p 6.43E-05 MAP3K1, MAP3K5, KRAS, MRAS, GRB2, FGF7
Endocytosis miR-33a-3p, −106b, −182, −374a, −374b, −202-5p 3.83E-04 RAB11FIP4, RAB11FIP2, EEA1, IGF1R, EPS15, EPN
Colorectal cancer miR-30b, −33a-3p, −106b, −132, −212, −384, −494 5.94E-04 SOS1, FZD3, SMAD2, DCC, MAPK1, BAX
Pathways in cancer miR-33a-3p, −107, −132, −212, −494, −495, −548j 5.95E-04 E2F1, FGF18, WNT16, FGF7, PTEN, MITF
Wnt signaling pathway miR-132, −212, −33a-3p, −494, −940, −495, −548j, −107 6.73E-04 LRP5, LRP6, TCF7, PLCB4, DVL3, WNT1, WNT5A
Neurotrophin signaling pathway miR-106b, −30b, −940, −182, −212, −107, 0.001267 PIK3R2, NTRK2, NTRK3, RPS6KA6, IRS1, RAC1
Oocyte meiosis miR-212, −132, −940, 495, −595, −107 0.003369 CDC27, CPEB1, PRKACB, FBXW11, MAPK1, RPS6KA3
GnRH signaling pathway miR-940, −495 0.007085 PRKCA, SRC, MAP3K2, MAPK14, GRB2, MAP3K3
Underexpressed miRNAs (Hyp vs. Unst)
Pathways in cancer miR-659, −141, −190, −449a, −200c, −361-5p, −145 9.51E-12 KRAS, PTEN, VEGFA, STAT5B, MITF, BCL2
MAPK signaling pathway miR-23a, −23b, −141, −145, −200c, −92a, −125b, −24 2.94E-11 MKNK2, MEF2C, FGF, SOS1, RAS, MAerkPK2
Wnt signaling pathway miR-125b, −449a, −302e, −145, −23a, −29b-2-5p, −659, −200c 2.76E-08 LRP5, LRP6, TCF7, PLCB4, DVL3, WNT1, WNT5A
ErbB signaling pathway miR-23a, −23b, −125b, −206, −302e, −513c 3.19E-07 ERBB4, GRB2, SHC1, PIK3R3, PIK3CD, AKT3
Colorectal cancer miR-659, 23a, −23b, −141, −190, −449a, −200c, −361-5p, −145 4.48E-07 DCC, APPL1, TGFBR2, SMAD3, SMAD4, APC
Axon guidance miR-23a, −23b, −200c, −145 7.23E-07 PLXNC1, EFNB2, PAK4, DCC, SEMA6A, PAK7, MET
Neurotrophin signaling pathway miR-302e, −361-5p, −452, −525-5p, −449a, −659 1.82E-06 NTRK2, NGFR, KRAS, MAP3K1, PIK3R3, PLCG1
Renal cell carcinoma miR-659, −141, −190, −449a, −200c, −361-5p, −145 3.75E-05 GAB1, MET, SOS1, GRB2, VEGFA, NRAS
Focal adhesion miR-24, −27b, −125a-3p, −139-5p, −206, −200c 5.04E-05 ITGB3, PXN, SHC3, ACTB, SRC, PAK2
Regulation of actin cytoskeleton miR-200c, −145, −27b, −92a, −300, −206 8.29E-05 RAC1, ROCK2, GIT1, PIK3R3, ITGA3, LIMK1
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Table 3 List of enriched pathways (P < 0.05), in which genes predicted to be targeted by differentially expressed miRNAs (P < 0.05)
in blood plasma of hyperstimulated vs. unstimulated heifers
Pathway name miRNA involved P value Top genes
Overexpressed miRNAs (hyp vs. unst)
Pathways in cancer let-7 g, miR- 20b-3p, −22, −26b-3p, −34a, −221, −181c 1.44E-09 AKT3, PIK3R3, RASSF1, KRAS, MEK, DCC
Wnt signaling pathway let-7 g, miR-221, −32 4.04E-08 WNT1, SMAD2, DKK2, DVL3, VANGL2, CCND1
Neurotrophin signaling pathway let-7 g, miR-22, −181c, −221 6.73E-08 NTRK2, IRS2, AKT3, NGF, PIK3CD, NRAS
Axon guidance miR-34a, −181c, −221 2.19E-07 PLXNC1, DPYSL2, PAK1, MET, KRAS, EFNB1
Endocytosis miR-22, −34a, −130b-3p, −576-5p 1.23E-06 TGFBR1, RAB5A, RAB11FIP4, PDCD6IP, VPS37A
MAPK signaling pathway let-7 g, miR-22, −32, −34a, −221 2.69E-06 RRAS, MAP3K1, MAPK1, MAPK9, SRF, MAP2K4
Colorectal cancer let-7 g, miR-22, −26b-3p, −24-2-5p 4.59E-06 DCC, TGFBR1, KRAS, MAP2K1, AKT3, CASP3
Chronic myeloid leukemia miR-22, −181c, −221 4.98E-06 NRAS, AKT2, BCR, MAPK1, GAB2, BCL2L1
TGF-beta signaling pathway miR-26b-3p, −221, −22, −32 9.63E-06 ACVR2A, TGFBR2, SMAD2, SMAD4, BMP7
ErbB signaling pathway miR-22, −181c, −221 2.96E-05 ERBB4, GAB1, MAP2K1, PAK4, PIK3CD
Underexpressed miRNAs (Hyp vs. Unst)
Pathways in cancer miR-125b, −153, −410, −494 9.51E-12 DCC, GRB2, SMAD2, SOS1, E2F3
MAPK signaling pathway mir-125b, −153, −494 2.94E-11 MEF2C, MAPKAPK2, MAP3K1, TGFB2, FGFR2
Wnt signaling pathway miR-147, −153, −410, −494 2.76E-08 LRP6, WNT5A, DVL3, DKK2, PLCB1, ANGL2
ErbB signaling pathway miR-125b, −410 3.19E-07 ERBB4, SOS1, MAPK1, NRG3, GAB1, MAP2K7
Colorectal cancer miR-125b, −410, −153, −494 4.48E-07 DCC, BCL2, SMAD4, RAF1, SMAD2, PIK3R3
Axon guidance miR-147, −153, −410, −494 7.23E-07 PLXNA2, ROCK2, EFNA3, NFAT5, MAPK1
Neurotrophin signaling pathway miR-125b, −134, −147, −494 1.82E-06 NTF3, MAP3K1, SOS1, SORT1, BCL2
Melanogenesis miR-134, −99a-3p 4.52E-06 MAPK1, WNT5A, KRAS, GNAI3, CREB1
Melanoma miR-125b, −494 1.70E-05 E2F2, FGFR1, IGF1R, FGF7, RAF1
Prostate cancer miR-125b, −147, −153, −410, −494 1.82E-05 FGFR2,, IGF1R, MAPK1, IGF1, BCL2
Fig. 4 Temporal expression of candidate circulatory miRNAs in blood plasma across estrous days. Relative expression of candidate circulatory
miRNAs in blood plasma of hypersitimulated heifers across different days during estrous (a-f) Expression of miR-221, miR-103, let-7g, miR-134,
miR-147 and miR-127-3p was determined by RT-qPCR and each miRNA expression level was normalized using global normalization method. The
error bars showed the SD. The significance of differences for miRNA expression was calculated using two-tailed T-test and *, p < 0.05. D0: onset of
estrous; D3: day 3 of estrous; D7: day 7 of estrous
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Detection of candidate circulatory miRNAs in exosomes
and Ago2 fraction of follicular fluid
Here we investigate the expression pattern of selected
candidate miRNAs in both exosomes and Ago2 fractions
of follicular fluid derived from hyperstimulated versus
unstimulated heifer groups. For this a total of six miR-
NAs representing those whose expression was induced
(miR-212, miR-182 & let-7 g) or suppressed (miR-100,
miR-877 and miR-200c) due to hyperstimulation were
selected for detecting their expression in exosome and
Ago2 fractions. The level of detection of candidate miR-
NAs was determined by real time PCR and data are
shown as raw Ct value in Fig. 6. As shown in this Fig. 6,
except miR-182, all candidate miRNAs were detected in
both exosomal and Ago2 fraction of follicular fluid of
both hyperstimulated and unstimulated animals. Mir-
182 was not detected in Ago2 fraction (with raw Ct
value more than 35) in both hyperstimulated and un-
stimulated heifers.
Detection of candidate circulatory miRNAs in exosomes
and Ago2 fraction of blood plasma
Here we have tried to detect candidate miRNAs, which
were enriched (miR-221, miR-103 & let-7 g) or sup-
pressed (miR-134, miR-147 & miR-127-3p) in blood
plasma samples of hyperstimulated animals compared to
the unstimulated ones. As shown in Fig. 7, all candidate
miRNAs, except miR-103 and miR-127-3p, were
Fig. 5 Specificity of isolation of exosomes and Ago2 protein complex from follicular fluid and blood plasma. Exosome and Ago2 proteins were
isolated from organic-phenol fraction during total RNA isolation using miRNeasy kit and resolved in 8M urea. Protein concentrations were quanti-
fied using Bradford assay and total of twenty microgram protein from each group were separated in 12 % SDS-PAGE, transferred nitrocellulose
membrane and incubated with specific antibody (CD63 and Ago2). Followed by HRP-conjugated secondary antibody and detected using chemi-
luminescent substrate. Western-blot results indicate the specificity of exosome and Ago2 protein isolation from follicular fluid (FF) and blood
plasma (BP) as indicated in the corresponding figures
Fig. 6 Detection of candidate extracellular miRNAs in exosomes and Ago2 fraction of follicular fluid derived from hyperstimulated and
unstimulated heifers. The boxplots on panels a through f represent the detection of candidate extracellular miRNAs in exosomes (Exo) or Ago2
protein complex (Ago2) fraction of follicular fluid samples derived from hyperstimulated (Hyp) and unstimulated (Unst) heifers. The error bars
show the SD. Data are presented as raw Ct value and Ct value of more than 35 was considered as undetected
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detected in both exosomal and Ago2 fraction of blood
plasma of both hyperstimulated and unstimulated
heifers. Mir-103 and miR-127-3p were not detected in
the Ago2 protein fraction of both treatment groups.
Discussion
Controlled ovarian hyperstimulation (COH) facilitate
growth of multiple follicles in monoovulatory animals.
COH involves stimulation of the ovaries by supraphysio-
logical levels of gonadotropins and also associated with
very low level of luteinizing hormone during the luteal
phase, the peri-implantation and implantation period
(Kolibianakis et al., 2006). Thus, the goal of COH is multi-
follicular recruitment with retrieval of multiple oocytes in
an effort to compensate for the “inefficiencies” of the out-
come of IVF laboratory. However, several reports showed
that, COH itself has adverse effects on oocyte develop-
ment, embryo quality, endometrial receptivity and perhaps
also perinatal outcomes [6, 7, 32] The effect of COH on
oviductal environment and subsequently on the transcrip-
tome of the resulting embryos has been evidenced [8].
Recently miRNAs have been detected in extracellular
environment mainly in different bio-fluids of various
species [15, 25, 33, 34]. Given the emerging association
of circulating miRNA species with a spectrum of patho-
physiological conditions, we have systematically explored
the changes in circulatory miRNAs in follicular fluid and
blood plasma induced by controlled ovarian hyperstimu-
lation. The results of this study clearly uphold our pri-
mary hypothesis that introduction of supra-physiological
level of gonadotropins during the process of COH may
induce the alteration of expression of extracellular miR-
NAs in follicular fluid as well as in blood plasma.
Since their discovery [13, 14], extracellular miRNAs
got a research priority as they have been found to be dif-
ferentially expressed in altered physiological conditions
[13]. Recently, it has been shown that a large number of
miRNAs are present in bovine follicular fluid and their
expression patterns differs depending on the growth sta-
tus of oocyte [15]. In the present study we profiled
extracellular miRNAs in bovine follicular fluid and blood
plasma derived from hyperstimulated and unstimulated
heifers using Human miRNome PCR array platform. A
specific miRNA transcript was considered as detected
when its Ct value <35 and present in at least 75 % of the
replicates. This selection criteria was set based on the
previous experiences in our lab with a similar study de-
sign [15]. Similar studies on detection of miRNAs in
plasma samples also use the same threshold level to de-
termine the detection level of transcripts [35], even as
high as ≤37 cycle as a threshold to determine the level
of detection of miRNAs in equine follicular fluid [36].
Despite using a heterologous approach, the quantitative
real time PCR analysis revealed a wide array of miRNAs
to be present in both follicular fluid and blood plasma,
indicating the cross species conservation feature of miR-
NAs between human and bovine as it has been observed
between wide range of species [37]. Of 748 miRNA in-
vestigated in the PCR array panel, a total of 504 and 402
miRNAs were detected in follicular fluid and blood
Fig. 7 Detection of candidate circulating miRNAs in exosomes and Ago2 fraction of blood plasma derived from hyperstimulated and unstimulated
heifers. The boxplots on panels a through f represent the detection of candidate extracellular miRNAs in exosomes (Exo) or Ago2 protein complex
(Ago2) fraction of blood plasma samples from hyperstimulated (Hyp) and unstimulated (Unst) heifers. The error bars show the SD of 4 replicates. Data
are presented as raw Ct value and Ct value of more than 35 was considered as undetected
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plasma, respectively. Comparable detection rate was also
reported for follicular fluid [15] and blood plasma [38].
Among the detected miRNAs, 373 were commonly found
in both follicular fluid and blood plasma. Results from this
study and our previous findings [15] confirmed that, rela-
tively higher number of extracellular miRNAs are present
in follicular fluid than blood plasma, which may be attrib-
uted to the condensed nature of the former.
By comparing hyperstimulated vs. unstimulated
heifers, 57 and 21 miRNAs were found to be differen-
tially regulated in follicular fluid and blood plasma, re-
spectively. Out of 57 differentially expressed miRNAs,
30 miRNAs were found to be up-regulated in follicular
fluid of hyperstimulated heifers. Several of these up-
regulated miRNAs have been reported to play an import-
ant role in follicular development and other physiological
processes. For instance, miR-212 & miR-132 were re-
ported to be involved in regulating follicular development
[39, 40]. Moreover, these two miRNAs (miR-212, −132)
were found to be significantly up-regulated in preovula-
tory mouse mural granulosa cells following LH/hCG in-
duction [41] indicating their potential involvement in
follicular development in those species. The miR-148*, a
minor form of miR-148, was also significantly up-
regulated in follicular fluid of hyperstimulated heifers. Al-
though, the role of this miRNA in follicular development
is unclear, miR-148/152 family was found to be important
for growth and development of normal tissue [42]. Inter-
estingly, miRNAs like miR-643, miR-548j, miR-224* and
miR-33b, which were found to be highly abundant in fol-
licular fluid of hyperstimulated heifers, are also reported
to be highly associated with cancer [43–46]. Among the
down-regulated miRNAs, miR-361-5p [47] and miR-27b
(homologous to miR-27a, sharing 20 out of 21 nts) [48]
were reported as tumor suppressors. Despite accumulated
evidences on the hormonal regulatory role of cellular miR-
NAs and vice versa [41], the present study is the first of its
kind reporting the effect of suprarphysiological level of go-
nadotropins on the level of circulating miRNAs in bovine
follicular fluid and blood plasma. However, the conse-
quence of this alteration on the resulting oocytes, embryos
and further ovarian function needs further investigation.
In blood plasma, 21 miRNAs were found to be differ-
entially expressed between hyperstimulated and un-
stimulated heifers where 13 miRNAs were up-regulated
and 8 miRNAs were down regulated. Among the up-
regulated miRNAs miR-708-3p, which showed the highest
fold change regulation, was reported in promoting the de-
velopment of bladder carcinoma via direct repression of
Caspase-2 [49]. Several studies have shown the association
of miR-26b, which was induced in expression due to hy-
perstimulation, with pregnancy-associated disorder like
preeclampsia [50]. The potential association of this
miRNA in reproductive disorder due to hyperstimulated
ovaries cannot be ruled out. Interestingly, miR-26b was
also reported to be elevated in plasma from severe pre-
eclamptic pregnancies [51]. MiR-221, which is commonly
known as oncomir, was also significantly elevated in blood
plasma of hyperstimulated heifers. In the present study we
also found a panel of down regulated miRNAs including
miR-153 and miR-134 which are commonly known as
tumor suppressor miRNA [52, 53].
Among the differentially expressed miRNAs in follicu-
lar fluid and blood plasma of hyperstimulated heifers, 13
miRNAs belong to 6 miRNA clusters suggesting the im-
portance of understanding the structure and function of
these miRNAs as clusters. miRNA clusters, which are
groups of tandem miRNA genes that are closely located
in the genome, are abundantly and widely distributed in
animal genomes. It has been revealed that about 50 % of
the miRNA genes in Drosophila [54] and over 30 % of
the miRNA genes in human, mouse, rat and chicken are
located in the genome as clusters [55]. The length of the
transcript typically varies from a couple of kb to over
10 kb. It has been reported that each miRNA cluster
usually has up to 10 miRNA genes [56]. Many of the
miRNA clusters may have one core promoter region and
transcriptional start site shared by all miRNA genes
within that cluster and are ultimately expressed within a
single RNA transcript [57]. Co-expression experiments
of clustered miRNA genes showed that one miRNA
cluster is usually transcribed as a single transcriptional
unit [58] as a result of some kind of regulatory coordin-
ation within the clustered miRNAs. In the present study,
we found that the miR-134 ~ 410 cluster which comprise
3 miR genes, while rest of the clusters has 2 miR genes
per cluster. Although several miRNA clusters have been
reported to be associated with pathological and physio-
logical conditions in human and mice, the overall ex-
pression pattern of extracellular miRNA clusters during
follicular development has not been extensively studied.
We have recently identified several classes of cluster
miRNAs in bovine follicular granulosa cells derived from
subordinate and dominant follicles during folliculogen-
esis [59, 60]. Since many miRNA genes within a cluster
share a common promoter or utilize common regulatory
machinery, examination of their expression pattern and
regulatory mechanism could enhance our understanding
of the role of extracellular miRNAs in the process of fol-
licular development.
Another interesting observation from our study is that
the number of differentially expressed miRNAs in follicu-
lar fluid is higher (57) than blood plasma (21) of hypersti-
mulated heifers. This is may be due to the fact that
gonadotropins action is specific to the target organs [61].
It has been well accepted that miRNAs are involved in
hormone regulation or vice versa [41]. FSH controls the
development of granulosa cells during folliculogenesis by
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stimulating their proliferation and differentiation, and by
promoting the formation of the follicular antrum. In par-
ticular, FSH enhances the biosynthesis of female sex hor-
mones estradiol and progesterone, which control the
estrous cycle and reproduction [62, 63]. Numerous studies
have shown that the LH surge initiates the transcriptional
upregulation and downregulation of genes, including cyto-
kines, transcription factors, and matrix-remodeling pro-
teins, within periovulatory granulosa cells [64, 65].
Therefore, the higher number of differentially regulated
miRNAs in follicular fluid of hyperstimulated heifers may
indicate the higher transcriptional activity of follicular cells
within follicular microenvironment during the process of
COH.
In addition to their expression level, we have investi-
gated the biological relevance of these differentially regu-
lated miRNAs. For this the target genes of differentially
expressed miRNAs were predicted bioinformatically and
the dominant biological pathways were determined. The
most significant pathways enriched by predicted targets
for up-regulated miRNAs in follicular fluid of hypersti-
mulated heifers including TGF-beta signaling pathway,
Axon guidance, neurotrophin signaling, MAPK signaling
colorectal cancer and pathways in cancer. All these path-
ways are known to be involved in ovarian follicular
growth, different developmental processes and also in
several pathological conditions. MiRNAs differentially
expressed in plasma samples were found to be involved
several pathways including cancer, WNT signaling path-
way Axon guidance, MAPK signaling pathways colorec-
tal cancer etc. Although the miRNA expression profiles
were different from each other, in silico predicted bio-
logical pathways were similar between follicular fluid
and blood plasma. This is consistent with the observa-
tion that the course of ovarian hyperstimulation may be
characterized by certain common pathways in the whole
physiology of the animal. However, it is important to
note that our observations for pathways are exploratory
in nature and need further validation using wet-lab stud-
ies to elucidate miRNA-mRNA interaction and causal
association of differentially expressed miRNAs and the
predicted pathways.
So far, it has been established that miRNAs are
expressed spatio-temporally in different developmental
process [66] and also in adult tissues [67]. A study con-
ducted with sheep ovarian tissues demonstrated differen-
tial expression of miRNA in follicles and corpora lutea
during the ovine oestrous cycle [68]. This study demon-
strated that eight miRNAs (miR-503, miR-21, miR-29b,
miR-142-3p, miR-34a, miR-152, miR-25 and miR-130a)
were highly expressed, while nine miRNAs (miR-125a,
miR-199a-3p, miR-125b, miR-99a, let-7c, miR-145, miR-
31, miR-202 and miR-27b) were expressed at lower level
between the follicular and luteal stages in ovine ovarian
tissues. In the present study temporal expression of miR-
NAs was observed in blood plasma of hyperstimulated
heifers across estrous cycle. For instance, miR-221, miR-
103, miR-134 and miR-127-3p show significantly higher ex-
pression at day 7 of estrous cycle compared to day 0 or day
3. In contrast, miR-147 has significantly lower expression
at day 7 of estrous. However, there is no significant differ-
ence in the expression of let-7 g across the estrous days.
Several studies have demonstrated that circulating
miRNAs may be coupled either with exosomes [21, 25]
or Ago2 protein complex [28] to bypass the high RNases
activity in blood stream or in follicular fluid. To proof
the mode of circulation of those miRNAs in follicular
fluid and blood plasma we have detected the expression
of candidate miRNAs in exosomal and Ago2 protein
fractions of both follicular fluid and blood plasma of
heifers in both treatment groups. The specificity of isola-
tion of exosome and Ago2 fraction was confirmed by
western blot analysis of CD63 and Ago2 protein [15, 69].
Candidates including miR-182 from follicular fluid
(Fig. 4) and miR-221, miR-103 and miR-127-3p from
blood plasma (Fig. 5) were found to be detected only in
exosomal fraction and completely undetected in the
Ago2 fraction. In both follicular fluid and blood plasma
samples, all miRNA which were detected in both frac-
tions, showed higher abundance in exosomal fraction
compared to the Ago2 protein complex. This is in agree-
ment with our previous findings showing that exosome
mediated release of miRNAs to be the dominant pathway
in follicular fluid [15]. Interestingly, the hyperstimulation
treatment had no effect on the detection of candidate
miRNAs either in exosomal or Ago2 protein complexes.
Conclusion
The present study demonstrated the consequence of
ovarian hyperstimulation in inducing changes in the rela-
tive abundance of extracellular miRNAs, which are poten-
tially involved in regulation of genes involved in several
physiological pathways. Moreover, the release of miRNAs
into extracellular space in both follicular fluid and blood
plasma was not affected by superstimulation treatment.
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